Literature DB >> 20219468

Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells.

Heidi A Schreiber1, Jozsef Prechl, Hongquan Jiang, Alla Zozulya, Zsuzsanna Fabry, Ferencz Denes, Matyas Sandor.   

Abstract

Dendritic cells (DCs) are crucial in the initiation of immune responses and are primary targets in vaccination. Here, we describe fluorescent, carbon magnetic nanoparticles (CMNPs) within the 20-80 nm size range that are non-toxic and preferentially endocytosed by DCs. These attributes allow for DC tracing in vitro, ex vivo and in vivo, by both fluorescence and MRI. We show that CMNPs conjugated with an array of proteins are able to induce strong immune responses in mice. The addition of TLR ligand, CpG, to the CMNPs along with protein results in both T cell activation, but also a selective IFNgamma response. The magnetism afforded by the CMNPs facilitates a simple DC enrichment ex vivo by magnetic means from both secondary lymphoid organs, and sites of chronic inflammation. The magnetic and fluorescent properties of the CMNPs allow for visualization, recovery, and potentially the facilitation of directed DC migration. These particles may support more efficient immunization protocols or new diagnostic assays to characterize functionalities of DCs from patients. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219468      PMCID: PMC2937839          DOI: 10.1016/j.jim.2010.02.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  47 in total

1.  Lack of dendritic cell maturation by the plant toxin ricin.

Authors:  Daniel C Smith; Mariolina Salio; J Michael Lord; Lynne M Roberts; Vincenzo Cerundolo
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

2.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

3.  Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice.

Authors:  Theodora Fifis; Patricia Mottram; Violeta Bogdanoska; Jennifer Hanley; Magdalena Plebanski
Journal:  Vaccine       Date:  2004-11-25       Impact factor: 3.641

4.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

Review 6.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Authors:  Paul J Tacken; I Jolanda M de Vries; Ruurd Torensma; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

7.  Detection of lymph node metastases by contrast-enhanced MRI in an experimental model.

Authors:  Patrick Wunderbaldinger; Lee Josephson; Christoph Bremer; Anna Moore; Ralph Weissleder
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

8.  Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.

Authors:  Javier Ochoa; Juan Manuel Irache; Ibai Tamayo; Alexander Walz; Vito G DelVecchio; Carlos Gamazo
Journal:  Vaccine       Date:  2007-04-02       Impact factor: 3.641

9.  In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice.

Authors:  Dirk Baumjohann; Andreas Hess; Lubos Budinsky; Kay Brune; Gerold Schuler; Manfred B Lutz
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

10.  Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

Authors:  Takami Akagi; Xin Wang; Tomofumi Uto; Masanori Baba; Mitsuru Akashi
Journal:  Biomaterials       Date:  2007-04-20       Impact factor: 12.479

View more
  9 in total

1.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Enhancement of DC-mediated anti-leukemic immunity in vitro by WT1 antigen and CpG co-encapsulated in PLGA microparticles.

Authors:  Liang Zhang; Sun Zhao; Jinhong Duan; Yan Hu; Ning Gu; Haiyan Xu; Xian-Da Yang
Journal:  Protein Cell       Date:  2013-12       Impact factor: 14.870

3.  Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.

Authors:  Dongchang Zhao; Darya Alizadeh; Leying Zhang; Wei Liu; Omar Farrukh; Edwin Manuel; Don J Diamond; Behnam Badie
Journal:  Clin Cancer Res       Date:  2010-11-18       Impact factor: 12.531

4.  Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Totan Ghosh; Sabyasachi Das; Satyajit Tripathy; Debasis Mandal; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2013-09-17       Impact factor: 3.358

5.  In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles.

Authors:  Shahanavaj Khan; Anees A Ansari; Abdul Arif Khan; Rehan Ahmad; Omar Al-Obaid; Wael Al-Kattan
Journal:  J Biol Inorg Chem       Date:  2015-11-12       Impact factor: 3.358

6.  Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development.

Authors:  S Chattopadhyay; S P Chakraborty; D Laha; R Baral; P Pramanik; S Roy
Journal:  Cancer Nanotechnol       Date:  2012-05-27

Review 7.  In Vivo MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells.

Authors:  Jeff W M Bulte; Ali Shakeri-Zadeh
Journal:  Mol Imaging Biol       Date:  2021-09-28       Impact factor: 3.484

8.  Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles.

Authors:  Liangran Guo; Daisy D Yan; Dongfang Yang; Yajuan Li; Xiaodong Wang; Olivia Zalewski; Bingfang Yan; Wei Lu
Journal:  ACS Nano       Date:  2014-05-13       Impact factor: 15.881

9.  Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.

Authors:  Honglin Jin; Yuan Qian; Yanfeng Dai; Sha Qiao; Chuan Huang; Lisen Lu; Qingming Luo; Jing Chen; Zhihong Zhang
Journal:  Theranostics       Date:  2016-09-02       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.